Literature DB >> 17406534

Restriction landmark genomic scanning.

Yoshinari Ando1, Yoshihide Hayashizaki.   

Abstract

Restriction landmark genomic scanning (RLGS) is a method to detect large numbers of restriction landmarks in a single experiment. It is based on the concept that restriction enzyme sites can serve as landmarks throughout a genome. RLGS uses direct end-labeling of the genomic DNA digested with a rare-cutting restriction enzyme and high-resolution two-dimensional electrophoresis. Compared with the conventional gene-detection technologies, such as Southern blot analysis and PCR, RLGS has the following advantages even though it needs specially designed instruments: high-efficiency scanning capacity, scanning extensibility by using alternate restriction enzyme combinations, applicability to any organism, a spot intensity that reflects the copy number of restriction landmarks, and the ability, by using a methylation-sensitive enzyme, to screen the methylated state of genomic DNA. The RLGS protocol can be accomplished in 5 days to 2 weeks.

Mesh:

Substances:

Year:  2006        PMID: 17406534     DOI: 10.1038/nprot.2006.350

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  5 in total

Review 1.  An overview of epigenetic assays.

Authors:  J Tyson DeAngelis; Woodrow J Farrington; Trygve O Tollefsbol
Journal:  Mol Biotechnol       Date:  2007-10-18       Impact factor: 2.695

2.  DNA methylation profiling in nanochannels.

Authors:  Shuang Fang Lim; Alena Karpusenko; John J Sakon; Joseph A Hook; Tyra A Lamar; Robert Riehn
Journal:  Biomicrofluidics       Date:  2011-07-25       Impact factor: 2.800

3.  Single DNA molecule patterning for high-throughput epigenetic mapping.

Authors:  Aline Cerf; Benjamin R Cipriany; Jaime J Benítez; Harold G Craighead
Journal:  Anal Chem       Date:  2011-10-13       Impact factor: 6.986

4.  Fused-core silica column ultra-performance liquid chromatography-ion trap tandem mass spectrometry for determination of global DNA methylation status.

Authors:  Ill Yang; Marie C Fortin; Jason R Richardson; Brian Buckley
Journal:  Anal Biochem       Date:  2010-10-13       Impact factor: 3.365

Review 5.  DNA methylation in peripheral blood: a potential biomarker for cancer molecular epidemiology.

Authors:  Lian Li; Ji-Yeob Choi; Kyoung-Mu Lee; Hyuna Sung; Sue K Park; Isao Oze; Kai-Feng Pan; Wei-Cheng You; Ying-Xuan Chen; Jing-Yuan Fang; Keitaro Matsuo; Woo Ho Kim; Yasuhito Yuasa; Daehee Kang
Journal:  J Epidemiol       Date:  2012-08-04       Impact factor: 3.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.